本研究报道了一例83岁高危患者在MitraClip（经导管二尖瓣钳夹术）术中突发右心房巨型模铸血栓的罕见病例。研究团队通过双颈动脉滤器（Emboshield NAV6）植入联合强化抗凝方案，成功完成TEER（经导管缘对缘修复术）并避免栓塞并发症，为介入心脏病学中急性血栓 ...

The clinical study report was submitted to FDA and results were published in peer-review journals. 11–13 The EXACT (EX) study was similarly initiated in November 2005, after FDA approval of the Xact ...

近期，南昌大学第一附属医院TAVR团队成功应用VenusA-Plus ®可回收输送系统在Emboshield Nav 6抗栓塞远端保护装置下为1例中重度主动脉瓣狭窄患者行经导管主动脉瓣置换术。手术圆满成功，患者预后良好。南昌大学第一附属医院TAVR团队对经导管主动脉瓣置换术（TAVR ...

近日，浙江大学医学院附属第一医院心内科郭晓纲教授团队为一例卒中高危风险的TYPE 1型二叶瓣重度主狭患者实施了Emboshield Nav⁶抗栓塞远端保护装置下的TAVR手术，获得圆满成功。 经导管主动脉瓣置换术（TAVR）已成为治疗症状性重度主动脉瓣狭窄的重要手段 ...

LAS VEGAS, NV—Asymptomatic women with carotid artery disease have fewer ipsilateral strokes over the long term when treated with carotid artery stenting (CAS) compared with carotid endarterectomy (CEA ...

LAS VEGAS, NV—On the rare occasion that carotid stents fracture, they do not appear to increase a patient’s risk of adverse events, according to a prespecified analysis of the ACT I trial presented ...

Previous clinical trials have suggested that carotid-artery stenting with a device to capture and remove emboli (“embolic protection”) is an effective alternative to carotid endarterectomy in patients ...